1887

Abstract

Biochemical studies have suggested that annexin 2 (A2) may participate in cytomegalovirus (CMV) infection. In the current work, effects of A2 monomer (p36) and heterotetramer (A2t; p36p11) were investigated. Demonstrating a role for endogenous A2, the four stages of infection that were followed were each inhibited by anti-p36 or anti-p11 at 37 °C. Immuno-inhibition was attenuated when the virus and cells were pre-incubated at 4 °C to coordinate virus entry initiated afterwards at 37 °C, reconciling controversy in the literature. As an explanation, CMV-induced phosphorylation of p36 was prevented by the 4 °C treatment. Supporting these immuno-inhibition data, purified A2t or p11 increased CMV infectious-progeny generation and CMV gene expression. A specific role for A2t was indicated by purified p36 having no effect. Unlike other steps, primary plaque formation was not enhanced by purified A2t or p11, possibly because of undetectable phosphorylation. As annexins 1 (A1) and 5 (A5) interact with A2, their effect on CMV was also tested. Both purified proteins inhibited CMV infection. In each experiment, the concentration of A1 required for half-maximal inhibition was five- to 10-fold lower than that of A5. Addition of A2 opposed A1- or A5-mediated inhibition of CMV, as did certain A2-specific antibodies that had no effect in the absence of added A1 or A5. Transfection of the p36-deficient cell line HepG2 increased CMV infection and was required for inhibition by the other annexins. These data suggest that CMV exploits A2t at physiological temperature to oppose the protection of cells conferred by A1 or A5.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82294-0
2007-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/1/19.html?itemId=/content/journal/jgv/10.1099/vir.0.82294-0&mimeType=html&fmt=ahah

References

  1. Andree H. A. M., Willems G. M., Hauptmann R., Maurer-Fogy I., Stuart M. C. A., Hermens W. T., Frederik P. M., Reutelingsperger C. P. M. 1993; Aggregation of phospholipid vesicles by a chimeric protein with the N-terminus of annexin I and the core of annexin V. Biochemistry 32:4634–4640 [CrossRef]
    [Google Scholar]
  2. Blackwood R. A., Ernst J. D. 1990; Characterization of Ca2+-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J 266:195–200
    [Google Scholar]
  3. Bold S., Ohlin M., Garten W., Radsak K. 1996; Structural domains involved in human cytomegaovirus glycoprotein B-mediated cell–cell fusion. J Gen Virol 77:2297–2302 [CrossRef]
    [Google Scholar]
  4. Brooks N. D., Grundy J. E., Lavigne N., Derry M. C., Restall C. M., Mackenzie C. R., Waisman D. M., Pryzdial E. L. G. 2002; Ca2+-dependent and phospholipid-independent binding of annexin 2 and annexin 5. Biochem J 367:895–900 [CrossRef]
    [Google Scholar]
  5. Chattopadhyay S., Sun P., Wong P., Abonyo B., Cross N. L., Liu L. 2003; Fusion of lamellar body with plasma membrane is driven by the dual action of annexin II tetramer and arachidonic acid. J Biol Chem 278:39675–39683 [CrossRef]
    [Google Scholar]
  6. Choi K.-S., Ghuman J., Kassam G., Kang H.-M., Fitzpatrick S. L., Waisman D. M. 1998; Annexin II tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry 37:648–655 [CrossRef]
    [Google Scholar]
  7. Compton T., Nowlin D. M., Cooper N. R. 1993; Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834–841 [CrossRef]
    [Google Scholar]
  8. Deora A. B., Kreitzer G., Jacovina A. T., Hajjar K. A. 2004; An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem 279:43411–43418 [CrossRef]
    [Google Scholar]
  9. Esclatine A., Bellon A., Michelson S., Servin A. L., Quéro A.-M., Géniteau-Legendre M. 2001; Differentiation-dependent redistribution of heparan sulfate in epithelial intestinal Caco-2 cells leads to basolateral entry of cytomegalovirus. Virology 289:23–33 [CrossRef]
    [Google Scholar]
  10. Feire A. L., Koss H., Compton T. 2004; Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A 101:15470–15475 [CrossRef]
    [Google Scholar]
  11. Glenney J. 1986; Two related but distinct forms of the M r 36,000 tyrosine kinase substrate (calpactin) that interact with phospholipid and actin in a Ca2+-dependent manner. Proc Natl Acad Sci U S A 83:4258–4262 [CrossRef]
    [Google Scholar]
  12. Hajjar K. A., Guevara C. A., Lev E., Dowling K., Chacko J. 1996; Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface: essential role of endonexin repeat 2. J Biol Chem 271:21652–21659 [CrossRef]
    [Google Scholar]
  13. Harder T., Gerke V. 1993; The subcellular distribution of early endosomes is affected by the annexin II2p112 complex. J Cell Biol 123:1119–1132 [CrossRef]
    [Google Scholar]
  14. Jacovina A. T., Zhong F., Khazanova E., Lev E., Deora A. B., Hajjar K. A. 2001; Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem 276:49350–49358 [CrossRef]
    [Google Scholar]
  15. Kang H. M., Kassam G., Jarvis S. E., Fitzpatrick S. L., Waisman D. M. 1997; Characterization of human recombinant annexin II tetramer purified from bacteria: role of N-terminal acetylation. Biochemistry 36:2041–2050 [CrossRef]
    [Google Scholar]
  16. Kari B., Gehrz R. 1992; A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J Virol 66:1761–1764
    [Google Scholar]
  17. Kari B., Gehrz R. 1993; Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. J Gen Virol 74:255–264 [CrossRef]
    [Google Scholar]
  18. Khanna N. C., Helwig E. D., Ikebuchi N. W., Fitzpatrick S., Bajwa R., Waisman D. M. 1990; Purification and characterization of annexin proteins from bovine lung. Biochemistry 29:4852–4862 [CrossRef]
    [Google Scholar]
  19. Köhler G., Hering U., Zschörnig O., Arnold K. 1997; Annexin V interaction with phosphatidylserine-containing vesicles at low and neutral pH. Biochemistry 36:8189–8194 [CrossRef]
    [Google Scholar]
  20. König J., Prenen J., Nilius B., Gerke V. 1998; The annexin II-p11 complex is involved in regulated exocytosis in bovine pulmonary artery endothelial cells. J Biol Chem 273:19679–19684 [CrossRef]
    [Google Scholar]
  21. Laumonnier Y., Syrovets T., Burysek B., Simmet T. 2006; Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 107:3342–3349 [CrossRef]
    [Google Scholar]
  22. Lee K. H., Na D. S., Kim J. W. 1999; Calcium-dependent interaction of annexin I with annexin II and mapping of the interaction sites. FEBS Lett 442:143–146 [CrossRef]
    [Google Scholar]
  23. Liu L., Tao J.-Q., Zimmerman U.-J. P. 1997; Annexin II binds to the membrane of A549 cells in a calcium-dependent and calcium-independent manner. Cell Signal 9:299–304 [CrossRef]
    [Google Scholar]
  24. Nowlin D. M., Cooper N. R., Compton T. 1991; Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J Virol 65:3114–3121
    [Google Scholar]
  25. Oshry L., Meers P., Mealy T., Tauber A. I. 1991; Annexin-mediated membrane fusion of human neutrophil plasma membranes and phospholipid vesicles. Biochim Biophys Acta 1066:239–244 [CrossRef]
    [Google Scholar]
  26. Peterson E. A., Sutherland M. R., Nesheim M. E., Pryzdial E. L. G. 2003; Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2. J Cell Sci 116:2399–2408 [CrossRef]
    [Google Scholar]
  27. Pietropaolo R. L., Compton T. 1997; Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J Virol 71:9803–9807
    [Google Scholar]
  28. Pietropaolo R., Compton T. 1999; Interference with annexin II has no effect on entry of human cytomegalovirus into fibroblast cells. J Gen Virol 80:1807–1816
    [Google Scholar]
  29. Pryzdial E. L. G., Wright J. F. 1994; Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 84:3749–3757
    [Google Scholar]
  30. Puisieux A., Ji J., Ozturk M. 1996; Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanism. Biochem J 313:51–55
    [Google Scholar]
  31. Raynor C. M., Wright J. F., Waisman D. M., Pryzdial E. L. G. 1999; Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry 38:5089–5095 [CrossRef]
    [Google Scholar]
  32. Rosales J. L., Ernst J. D. 1997; Calcium-dependent neutrophil secretion: characterization and regulation by annexins. J Immunol 159:6195–6202
    [Google Scholar]
  33. Sutherland M. R., Raynor C. M., Leenknegt H., Wright J. F., Pryzdial E. L. G. 1997; Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A 94:13510–13514 [CrossRef]
    [Google Scholar]
  34. Wang X., Huong S.-M., Chiu M. L., Raab-Traub N., Huang E.-S. 2003; Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424:456–461 [CrossRef]
    [Google Scholar]
  35. Wright J. F., Kurosky A., Wasi S. 1994; An endothelial-cell surface form of annexin II binds human cytomegalovirus. Biochem Biophys Res Comm 198:983–989 [CrossRef]
    [Google Scholar]
  36. Wright J. F., Kurosky A., Pryzdial E. L. G., Wasi S. 1995; Host cellular protein annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J Virol 69:4784–4791
    [Google Scholar]
  37. Zeibdawi A. R., Grundy J. E., Lasia B., Pryzdial E. L. G. 2004; Coagulation factor Va Glu-96–Asp-111: a chelator-sensitive site involved in function and subunit association. Biochem J 377:141–148 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82294-0
Loading
/content/journal/jgv/10.1099/vir.0.82294-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error